期刊文献+

喹硫平治疗老年期痴呆患者行为和精神症状的临床观察 被引量:7

下载PDF
导出
摘要 目的探讨喹硫平治疗老年期痴呆患者行为和精神症状的疗效及不良反应,并与利培酮治疗作对照。方法将62例老年期痴呆患者随机分为喹硫平组和利培酮组,疗程8周。采用阿尔茨海默病病理行为评定表(BEHAVE—AD)及症状量表(TESS)评定疗效及不良反应。结果喹硫平与利培酮对老年期痴呆患者行为和精神症状疗效相当。有效率喹硫平组为87.10%,利培酮组为83.90%。不良反应少。结论喹硫平治疗老年期痴呆患者行为和精神症状安全有效,副反应轻而少,适用于老年患者。
作者 韦红日
出处 《海南医学》 CAS 2009年第10期49-50,共2页 Hainan Medical Journal
  • 相关文献

参考文献3

二级参考文献12

  • 1孙新宇,高之旭,冯锋,温全球,冯少慧,盛建华,陈建,苗国栋,于欣.氟哌啶醇与利培酮治疗痴呆患者精神行为症状的随机双盲对照研究[J].中华精神科杂志,2004,37(3):156-159. 被引量:54
  • 2高之旭,盛建华.阿尔茨海默病精神障碍及治疗的进展[J].老年医学与保健,1999,5(1):9-11. 被引量:19
  • 3Zarate CA, Baldessarini Pd,Siegal AJ ,et al. Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry, 1997,58 ( 3 ) :311 -317.
  • 4Schneider L, Pollock VE, Lyness SA. A meta analysis of controlled trials of neuroleptlc treatment of dementia. J Am C, edatr Sac, 1990,38(4) :553 -563.
  • 5Hinchcliffe AC,Hyman IL, Blizant B,et al. Behavioral complications of dementia can they be treated? Int J C, efiatr Psychiatry, 1995,10(7) :839 -847.
  • 6Barbee JG, Conrad EJ, Jamhour NJ. The effectiveness of olanzapine,risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder [ J ]. J Clin Psychiatry, 2004,65: 975-981.
  • 7Cheer SM, Wagstaff AJ. Quetiapine: A review of its use in the management of schizophrenia[J]. CNS Drugs,2004,18:173-199.
  • 8Devanand DP,Jacobs DM, Tang MX,et al. The course of psychopathologic features in mild to moderate Alzheimer disease[ J ]. Arch Gen Psychiatry, 1997,54 : 257-263.
  • 9Reisberg B, Borertstein J, Salob SP, et al. Behavioral symptoms in Alzheimer' s disease: phenomenology and treatment [ J ]. J Clin Psychiatry, 1987,48:9-15.
  • 10Fujikawa T, Takahashi T, Kinoshita A, et al. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type[J]. Neuropsychobiology,2004,49:201-204.

共引文献34

同被引文献51

  • 1黄文武,姜德国.抗精神病新药阿立哌唑[J].上海精神医学,2003,15(5):307-308. 被引量:153
  • 2侯振成,刘立芳,李淑香,郭汲源.喹硫平治疗老年期痴呆患者行为和心理症状的临床观察[J].中国民康医学,2006,18(15):643-645. 被引量:6
  • 3于靖,王传跃,翁永振,刘瑞玫,姜荣环,邸晓兰,姚付新,王锦霞,朱凤艳,沈建华,杨桂伏,高昕,何静.伴月经紊乱的精神分裂症女性患者换用喹硫平后一年的随访[J].中华精神科杂志,2007,40(3):161-164. 被引量:10
  • 4沈渔邨.精神病学[M].第5版.北京:人民卫生出版社,2009:215.
  • 5杨德森,姚芳传,陈彦芳,等.中国精神障碍分类与诊断标准CCMD-3[M].济南:山东科学技术出版社,2001.104-105.
  • 6张明园.精神科评定量表手册[M].2版,长沙:湖南科学技术出版社,2003.
  • 7Gorwood P, Peuskens J. Setting new standards in schizophrenia out- comes: Symptomatic remission 3 years before versus after the an- dreasen criteria [J]. European Psychiatry, 2012, 27: 170-175.
  • 8Shana GS, Jason S, Emily K, et al. Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizo- phrenia-spectrum disorder: a high-risk prospective investigation [J]. Schizophrenia Research, 2012, 139: 129-135.
  • 9Fountoulakis KN, Vieta E, Schmidt F. Aripiprazole monotherapy in the treatment of bipolar disorder: A meta-analysis [J]. Journal of Af- fective Disorders, 2011, 133: 361-370.
  • 10Gorwood P, Peuskens J. Setting new standards in schiz- ophrenia outcomes: symptomatic remission 3 years before versus after the Andreasen criteria [J]. Eur Psychiatry, 2012, 27(3): 170.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部